This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Advanced Solid Malignancies
and you are
over 19
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The main objective of this study is to determine the maximum tolerated dose (MTD) of HM781-36B continuously.

Provided treatments

  • Drug: HM781-36B tablets

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455584. The sponsor of the trial is Hanmi Pharmaceutical Company Limited and it is looking for 20 volunteers for the current phase.
Official trial title:
Phase Ⅰ Study to Determine the Maximum Tolerated Dose of HM781-36B Continuously Given in Patients With Advanced Solid Tumors and to Assess the Food Effect on Pharmacokinetic Profile